Advanced Cardiovascular Lipid Profile (ACVLP)
What is the Advanced Cardiovascular Lipid Profile (ACVLP)?
This is a customized group of tests specifically designed to predict those at risk for developing cardiovascular disease (heart attack and stroke). It is a more accurate way to determine individual risk factors for heart disease than the standard lipid profile that only measures total cholesterol, triglycerides and the total good (HDL) and bad (LDL) cholesterol. It includes these values in addition to measuring the number, size and density of the 7 subcategories of LDL and 5 subcategories of HDL, giving a more complete picture of your state of health. The ACVLP measures seven other independent inflammatory markers for a comprehensive cardiovascular disease risk assessment. The research laboratory uses standardized, gold standard methods for these tests.
What are Benefits of Including ACVLP with APO E Genetic Test?
A more comprehensive assessment is achieved that allows for an individualized plan to reduce cardiovascular (CV) disease risk. Research has shown improved outcomes using such CV disease risk reduction programs. Some APO E genotypes respond very quickly to dietary changes. It is possible to convert an unhealthy pattern B LDL (small, dense bad cholesterol) to a healthier pattern A LDL (light, fluffy bad cholesterol) and dramatically decrease total and bad LDL cholesterol and triglyceride levels through diet, thereby reducing CV disease risk.
Barbara's APO E Gene Diet program is endorsed by Pam McDonald, the author of the APO E Gene Diet book and developer of the program.
